Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?

Bullous pemphigoid (BP) is the most frequent autoimmune subepidermal bullous disease. At present, the main treatment options are represented by corticosteroids and immunosuppressant drugs. Steroids often need to be administered in high doses, with subsequent adverse events and safety issues, as BP m...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Roberto, Capurro, Niccolò, Cozzani, Emanuele, Parodi, Aurora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224939/
https://www.ncbi.nlm.nih.gov/pubmed/35743438
http://dx.doi.org/10.3390/jcm11123367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224939/
https://www.ncbi.nlm.nih.gov/pubmed/35743438
http://dx.doi.org/10.3390/jcm11123367

Ejemplares similares